Vycor Medical Inc
VYCO· OTC
VYCOVycor Medical Inc
Filed Aug 9, 2019 · 10-Q · 40 days after period end · 0001493152-19-011972
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $411.90K | $301.67K | $307.68K | $379.41K |
| Net Income | -$185.30K | -$418.58K | -$360.72K | -$305.36K |
| EPS Diluted | -$0.01 | -$0.02 | -$0.02 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 9, 2019 · 40 d after period end
